Does Saw Palmetto Work? A Balanced Review of the Clinical Evidence

Saw palmetto is the most widely used botanical supplement for prostate health globally. But the clinical evidence is more nuanced than most product labels suggest. This article examines what the research actually shows.

This article is for educational purposes only. Consult a physician before starting any supplement.

What Is Saw Palmetto?

Saw palmetto (Serenoa repens) is a lipophilic extract derived from the berries of a small palm native to the southeastern United States. The standardized extract, typically standardized to 85% or more total fatty acids, is the form used in clinical trials. Crude berry powder found in cheaper supplements has not demonstrated comparable efficacy and should not be conflated with standardized extract.

Proposed Mechanisms

  • 5-alpha-reductase inhibition: Inhibits the enzyme that converts testosterone to DHT, the primary androgen driving prostate tissue growth in BPH
  • Anti-inflammatory activity: Inhibits COX-1 and COX-2 enzymes, reducing prostatic inflammation
  • Alpha-adrenergic antagonism: May reduce urethral tone and improve urine flow
  • Anti-estrogenic effects: May inhibit estrogen receptors in prostate tissue
PubMed: Paubert-Braquet et al. - Saw Palmetto Mechanisms

The Positive Evidence

A landmark systematic review by Wilt et al. published in JAMA (2000) pooled 18 randomized trials involving 2,939 men and found that saw palmetto significantly improved urinary symptom scores and peak urinary flow rates versus placebo. Men receiving saw palmetto were nearly twice as likely to report symptom improvement.

A direct comparison RCT by Debruyne et al. in European Urology (2002) found that Permixon, a standardized saw palmetto extract, produced comparable improvements to tamsulosin (Flomax) in IPSS and peak flow rate, with fewer side effects including no impact on ejaculation or blood pressure.

PubMed: Wilt TJ et al. - Saw Palmetto Meta-Analysis (JAMA 2000)PubMed: Debruyne et al. - Permixon vs Tamsulosin RCT

The Controversial Evidence

Two large NIH-funded trials - STEP (2006) and CAMUS (2011) - found no significant difference between saw palmetto and placebo on IPSS scores or urinary flow rates. These trials have been widely cited as evidence against saw palmetto. However, both used a commercially available product (Nature's Way brand) rather than the Permixon extract used in positive European trials. The fatty acid standardization and bioactive composition varies significantly between extracts, and critics argue the STEP and CAMUS trials tested a different, less bioactive product.

PubMed: Bent S et al. - STEP Trial (NEJM 2006)PubMed: Barry MJ et al. - CAMUS Trial (JAMA 2011)

Why Extract Quality Is the Critical Variable

The saw palmetto literature is a case study in why supplement quality matters. A 2012 analysis found dramatic variation in the fatty acid content of commercial saw palmetto products, with some containing less than 20% of the labeled amount of active compounds. The key variable appears to be extract standardization: trials using highly standardized lipophilic extracts (85%+ fatty acids, typically Permixon) have predominantly shown positive results, while trials using non-standardized commercial products have predominantly shown no effect.

Current Guideline Position

The AUA guidelines on BPH do not currently recommend saw palmetto as a standard treatment, citing inconsistent evidence. The European Association of Urology takes a more permissive position, noting that standardized phytotherapeutics including saw palmetto have demonstrated efficacy in randomized trials and represent a reasonable option for men who prefer to avoid pharmaceutical side effects.

AUA BPH Clinical Guidelines

The Verdict

Standardized saw palmetto extract (85%+ fatty acids) at 320 mg/day has demonstrated efficacy comparable to tamsulosin in at least one direct comparison trial and showed significant benefit in 18 pooled trials. The negative STEP and CAMUS trials used a less bioactive product. If you choose to use saw palmetto, extract standardization and product quality are the critical variables, as is using it at the clinically studied dose for a minimum of 12 to 24 weeks.

Saw Palmetto in Complete Prostate Health

Complete Prostate Health by Aleaf Labs (NPN 80087894) uses standardized saw palmetto extract as part of a six-ingredient Health Canada-licensed formula alongside beta-sitosterol, pygeum, nettle root, zinc, and lycopene. Learn more about Complete Prostate Health.

References: Wilt TJ et al. JAMA 2000;283(13):1604-1609; Debruyne F et al. Eur Urol 2002;41(5):497-507; Bent S et al. NEJM 2006;354(6):557-566; Barry MJ et al. JAMA 2011;306(12):1344-1351; AUA BPH Guidelines 2022. This article is for informational purposes only.